{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:27:09Z","timestamp":1793388429168,"version":"4.5.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100010198","name":"Health Institute Carlos III (Spanish Ministry of Economy, Industry and Innovation","doi-asserted-by":"publisher","award":["FIS PI19\/00570"],"award-info":[{"award-number":["FIS PI19\/00570"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Health Institute Carlos III (Spanish Ministry of Economy, Industry and Innovation)","doi-asserted-by":"publisher","award":["CP16\/00082"],"award-info":[{"award-number":["CP16\/00082"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Alzheimer\u2019s (AD) and Parkinson\u2019s diseases (PD) show deposits of improperly\nfolded modified proteins. Protein expression mechanisms are involved since the early stages. Several\nstudies evaluated epigenomics and proteomics profiles in these patients, with promising results. In\ngeneral, they focused on early, specific, and minimally invasive biomarkers for the diagnosis and\nprognosis of AD and PD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This review aimed at summarizing results to find the most reliable evidence in the field.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Among epigenomics studies, there is a focus on microRNAs (miRNAs) as candidate diagnostic\nbiomarkers for AD or PD from blood samples like miR-342-3p, miR-107, miR-106a-5p, miR-106b-\n5p, miR-195, and miR-19b. In addition, DNA methylation has been tested in a few works, obtaining\nsignificant differences in some genes (NCAPH2\/LMF2 COASY, SPINT1, BDNFTREM1, TREM2,\nNPAS2, PDE4D), which could be useful for evaluating the disease progression as well as potential risk\nfactors. Regarding proteomics, most of the studies were untargeted and used plasma or serum samples.\nIn general, they highlighted the importance of coagulation, inflammation pathways, and oxidative\nstress. Among targeted studies, some proteins (phosphorylated tau, C reactive protein (CRP), interleukins,\nnecrosis factors, transferrin, glial fibrillary acidic protein (GFAP), and neurofilaments) showed\ndifferent plasma levels in AD and PD patients in comparison with healthy participants. Finally, a few\nstudies have identified specific-AD and PD epigenetic and proteomic biomarkers (ApoE and oxidized\nDJ-1) in comparison with other similar pathologies.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> In general, there is a common lack of clinical validation of these potential biomarkers because\nof which its use in clinical practice is still limited.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1570159x19666201223154009","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T06:18:39Z","timestamp":1608790719000},"page":"1273-1303","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Recent Evidence in Epigenomics and Proteomics Biomarkers for Early and Minimally Invasive Diagnosis of Alzheimer\u2019s and Parkinson\u2019s Diseases"],"prefix":"10.2174","volume":"19","author":[{"given":"Sonia","family":"Mayo","sequence":"first","affiliation":[{"name":"Oxidative Pathology Research Group, Health Research Institute INCLIVA, Valencia,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juli\u00e1n","family":"Benito-Le\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital 12 de Octubre, Madrid,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Pe\u00f1a-Bautista","sequence":"additional","affiliation":[{"name":"Neonatal Research Unit, Health Research Institute La Fe, Valencia,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Baquero","sequence":"additional","affiliation":[{"name":"Neurology Unit, University and Polytechnic Hospital La Fe, Valencia,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Ch\u00e1fer-Peric\u00e1s","sequence":"additional","affiliation":[{"name":"Neonatal Research Unit, Health Research Institute La Fe, Valencia,Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X19666201223154009","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/189433\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X19666201223154009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T13:24:10Z","timestamp":1655385850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/189433\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x19666201223154009","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-07-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-27","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}